Back to search results

Tofersen in Non-SOD1 ALS

Abroad (travel likely)RecruitingPHASE2

Conditions

ALS (Amyotrophic Lateral Sclerosis)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Emory University, Atlanta, Georgia, United States

    Contact: Study coordinator (Karon Simmons) · kmsimm2@emory.edu · 404-712-4182
    Contact: Principal Investigator (Jonathan Glass, MD)

  • Massachusetts General Hospital, Boston, Massachusetts, United States

    Contact: Study coordinator (Miranda Durcan) · tofersensporadichealey@mgb.org · 617-643-9550
    Contact: Principal Investigator (Suma Babu, MBBS, MPH)

  • Washington University ALS Center, St Louis, Missouri, United States

    Contact: Study coordinator (ALS Clinical Research Team) · als@wustl.edu · 1-844-257-2273
    Contact: Principal Investigator (Timothy M Miller, MD, PhD)
View source on ClinicalTrials.gov(opens in a new tab)